Andrea Di Lorenzo
Overview
Explore the profile of Andrea Di Lorenzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kontogiannis D, Di Lorenzo A, Zace D, Benvenuto D, Moccione M, Muratore G, et al.
Front Microbiol
. 2024 Jul;
15:1418530.
PMID: 38993488
var. , is a dimorphic fungus that causes histoplasmosis. It usually affects people coming from endemic areas, causing a variety of clinical manifestations up to progressive disseminated histoplasmosis (PDH), especially...
2.
Imeneo A, Rindi L, Di Lorenzo A, Cavasio R, Vitale P, Spalliera I, et al.
BMC Infect Dis
. 2024 Jan;
24(1):109.
PMID: 38245682
Background: Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Here we...
3.
Di Lorenzo A, Rindi L, Campogiani L, Imeneo A, Alessio G, Pace P, et al.
Chemotherapy
. 2023 Nov;
69(2):85-99.
PMID: 37963447
Introduction: Acute eosinophilic pneumonia (AEP) is a rare respiratory condition caused by eosinophil accumulation in the pulmonary tissue that can be related to drug administration. Daptomycin, an antibiotic active against...
4.
Di Lorenzo A, Campogiani L, Iannetta M, Iannazzo R, Imeneo A, Alessio G, et al.
Antibiotics (Basel)
. 2023 Sep;
12(9).
PMID: 37760645
Co-infections during COVID-19 may worsen patients' outcomes. This study reports the results of a screening assessing the presence of co-infections among patients hospitalized for SARS-CoV-2 infection in the Infectious Diseases-Ward...
5.
Bellocchi M, Scutari R, Carioti L, Iannetta M, Marchegiani G, Piermatteo L, et al.
Viruses
. 2023 Aug;
15(8).
PMID: 37632054
In this study, we provided a retrospective overview in order to better define SARS-CoV-2 variants circulating in Italy during the first two years of the pandemic, by characterizing the spike...
6.
Campogiani L, Iannetta M, Di Lorenzo A, Zordan M, Pace P, Coppola L, et al.
Microorganisms
. 2023 Feb;
11(2).
PMID: 36838277
There are still conflicting data on the virological effects of the SARS-CoV-2 direct antivirals used in clinical practice, in spite of the documented clinical efficacy. The aim of this monocentric...
7.
Di Lorenzo A, Tedde S, Pace P, Campogiani L, Ansaldo L, Lodi A, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359306
Lymphopenia has been consistently reported as associated with severe coronavirus disease 2019 (COVID-19). Several studies have described a profound decline in all T-cell subtypes in hospitalized patients with severe and...
8.
Alessio G, Imeneo A, Di Lorenzo A, Rossi B, Sorace C, Compagno M, et al.
Microbiol Spectr
. 2022 Sep;
10(5):e0185822.
PMID: 36098523
No abstract available.
9.
Iannetta M, Crea A, Di Lorenzo A, Campogiani L, Teti E, Malagnino V, et al.
Open Forum Infect Dis
. 2022 Sep;
9(9):ofac451.
PMID: 36092833
HIV and hepatitis B virus (HBV) coinfection is relatively common. Initiation of antiretroviral therapy (ART) in people with HIV (PWH) causes a progressive restoration of cell-mediated immune functions. In the...
10.
Imeneo A, Alessio G, Di Lorenzo A, Campogiani L, Lodi A, Barreca F, et al.
Life (Basel)
. 2022 Feb;
12(2).
PMID: 35207531
Increased rates of indeterminate QuantiFERON-TB Gold Plus Assay (QFT-Plus) were demonstrated in patients hospitalized with Coronavirus Disease (COVID)-19. We aimed to define the prevalence and characteristics of hospitalized COVID-19 patients...